Search - tctmd.com

Displaying 21 - 40 of 357

Sort: Relevancy | Date

Presentation Complex Coronary Cases 2023

PCI vs CABG vs OMT in Patients with LV Dysfunction: PCI is the Treatment of Choice (for most patients)

Presenter: Gregg W. Stone

June 15, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Daily News

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Michael O'Riordan

February 15, 2023

Presentation AHA 2022

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

Presenter: Gregg W. Stone

November 07, 2022

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

Presentation TCT 2022

It’s About Time We Started Assessing and Treating Vulnerable Plaque

Presenter: Gregg W. Stone

September 18, 2022

Presentation TCT 2022

COSIRA-II – Trial Design and Status Update

Presenter: Gregg Stone

September 18, 2022

Presentation TCT 2022

We Should Be Offering More PCI to Patients With Complex Multivessel Disease

Presenter: Gregg W. Stone

September 17, 2022

Presentation TCT 2022

The V-Wave Study: Different Device, Different Study Population, and Perhaps Different Results?

Presenter: Gregg W. Stone

September 17, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Conference News SCAI 2022

Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion

L.A. McKeown

May 19, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

Presentation CTO 2022

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

Presenter: Gregg Stone

February 25, 2022

News Daily News

SCAI-Defined Perioperative MIs Too Numerous to Be Useful in Cardiac Surgery

Michael O'Riordan

February 03, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

Presentation Controversies and Advances 2021

Optimal Management of Left Main Disease in 2021

Presenter: Gregg W. Stone

December 03, 2021

News Conference News AHA 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Michael O'Riordan

November 15, 2021

Advertisement

PCI vs CABG vs OMT in Patients with LV Dysfunction: PCI is the Treatment of Choice (for most patients)

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

It’s About Time We Started Assessing and Treating Vulnerable Plaque

COSIRA-II – Trial Design and Status Update

We Should Be Offering More PCI to Patients With Complex Multivessel Disease

The V-Wave Study: Different Device, Different Study Population, and Perhaps Different Results?

Less Death, Major Bleeding With Transradial Access: Meta-analysis

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Is CABG Really the Best Primary Approach to Multivessel/LMCA Disease? Interventional Perspectives

SCAI-Defined Perioperative MIs Too Numerous to Be Useful in Cardiac Surgery

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Optimal Management of Left Main Disease in 2021

No Mortality Difference Between PCI and CABG for Left Main CAD: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content